Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Immunovaccine’s targeted ovarian cancer therapy wins orphan drug status in EU
Immunovaccine’s targeted ovarian cancer therapy wins orphan drug status in EU
Immunovaccine’s targeted ovarian cancer therapy wins orphan drug status in EU
Submitted by
admin
on November 22, 2016 - 9:52pm
Source:
Drug Delivery Business
News Tags:
Immunovaccine
ovarian cancer
Europe
DPX-Survivac
Headline:
Immunovaccine’s targeted ovarian cancer therapy wins orphan drug status in EU
Do Not Allow Advertisers to Use My Personal information
